Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].

Nihon rinsho. Japanese journal of clinical medicine - 1 Aug 2001

Yamazoe Y, Nagata K

Abstract excerpt

Genetic polymorphisms of drug metabolizing enzymes often associated with clinical alteration among individuals. Current understanding of the molecular basis of the polymorphism of drug metabolizing enzymes is reviewed, particularly on cytochrome P450(CYP). Pharmacogenetic/pharmacogenomic studies are started for the estimation of pharmacokinetics of drugs, but now expanding for a tool of individual optimization of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Cytochrome P-450 Enzyme System
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 11519169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].PMID 11519169Read ↗

[Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C].Semantic proximity Read ↗

[Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].Semantic proximity Read ↗

Advances in human cytochrome p450 and personalized medicine.Semantic proximity Read ↗

[Genetic polymorphisms in drug-metabolizing enzymes].Semantic proximity Read ↗

[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].Semantic proximity Read ↗

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Semantic proximity Read ↗

Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical SignificanceSemantic proximity Read ↗

[Genetic polymorphism of drug metabolizing enzymes].Semantic proximity Read ↗

Genetic polymorphism of cytochrome P450 and methods for its determination.Semantic proximity Read ↗

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese PopulationSemantic proximity Read ↗

Pharmacogenetics of cytochrome P450 (CYP) in the elderly.Semantic proximity Read ↗

Cytochrome P450 in Pharmacogenetics: An Update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.